Table 4. Linear regression analyses for associations between clinical variables and the intimal thickening (%IA) of pulmonary arteries in the overall population.
Dependent variable:% Intimal area | Univariateβ coefficient [95% CI] | p-value |
---|---|---|
Male gender | -2.77 [-11.78–6.25] | 0.530 |
Age | 0.109 [-0.23–0.45] | 0.515 |
BMI | -0.06 [-1.09–0.97] | 0.902 |
Pack-years | 0.09 [-0.04–0.23] | 0.163 |
Emphysema | -1.79 [-9.83–6.24] | 0.647 |
Systemic hypertension | -1.21 [-12.65–10.23] | 0.827 |
Diabetes Mellitus | -4.61 [-12.22–2.99] | 0.223 |
Metabolic syndrome | 0.94 [-9.01–10.89] | 0.844 |
Lipid lowering | 3.37 [-2.47–9.20] | 0.247 |
ACEIs/ARBs | 1.52 [-8.16–11.19] | 0.746 |
Inhaled CS | 4.32 [-5.91–14.55] | 0.391 |
Leukocytes | -0.86 [-2.38–0.65] | 0.252 |
COPD | 10.23 [4.37–16.09] | 0.001 |
BMI: body mass index, ACEIs/ARBs: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, CS: corticosteroids.